Dietary flavan-3-ols have received increasing interest recently, with clinical trials underway to determine the effects of EGCG on cognitive decline in carriers of the AD risk gene APOE4 (PENSA; NCT03978052) and cocoa flavonoid intervention on cognitive decline in the aging population (COSMOS-Mind study; NCT03035201). This evidence concerns the gene APOE and Alzheimer disease.